0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Decision Diagnostics
Its shares trade under the ticker DECN. It has been listed since 8 February 2002. In the fiscal year to 31 December 2020, it reported revenue of $2.0m and a net loss of $29.7m. At that date it held total assets of $5.7m and shareholders' equity of $483,594.
Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The company is headquartered in Westlake Village, California. The company went IPO on 2002-02-08. The firm is a manufacturer of the Genstrip 50 and GenUltimate! Glucose test strips, class II medical devices for at-home use for the measurement of glucose. The company distributes several lines of ostomy, wound care and post-surgery medical products. The company provides smart phone-based electronic medical record (EMR) applications to be used by physicians at the point of care. Its technologies manage data and e-commerce, as well as facilitate communication using smartphone and personal digital assistant (PDA) applications in the healthcare, apartment and elderly care industries. Its technology includes MD@Hand, a computer/smartphone-based program, which links the physician to the pharmacy and healthcare provider. The company also offers ResidenceWare, which is a collection of Internet-enhanced communication, integration and networking tools developed for the real estate marketplace.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 8 Feb 2002
- Employees
- 5
- Website
- decisiondiagnostics.co ↗
Leadership
Pay as last reported
- Robert JagunichDirector$86,250
- William LyonsDirector$57,500
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Decision Diagnostics Corp has several strengths that contribute to its competitive advantage in the market. Firstly, the company possesses advanced technological capabilities, allowing them to develop innovative products and solutions. Additionally, Decision Diagnostics Corp has a strong intellectual property portfolio, providing them with a competitive edge over rivals. Moreover, the company has a skilled and dedicated workforce that drives their success and enables them to deliver high-quality products and services.
Weaknesses
- Despite its strengths, Decision Diagnostics Corp also faces certain weaknesses that need to be addressed. One prominent weakness is the company's limited market share, which restricts their overall growth potential. Additionally, the company's current financial position may pose challenges in terms of obtaining necessary funding for future expansion and development projects. Furthermore, Decision Diagnostics Corp may face difficulties in effectively managing their supply chain and distribution network, resulting in potential operational inefficiencies.
Opportunities
- Decision Diagnostics Corp has various opportunities that can be capitalized on to fuel their growth and market presence. Firstly, the increasing global demand for advanced diagnostic technologies presents a significant opportunity for the company to expand its customer base and revenue streams. Furthermore, strategic partnerships and collaborations with healthcare organizations can open doors for entering new markets and developing cutting-edge solutions. Moreover, the growing emphasis on digital healthcare solutions provides Decision Diagnostics Corp with a chance to leverage their technological expertise to offer efficient and convenient remote diagnostic services.
Threats
- Decision Diagnostics Corp faces certain threats that could potentially hinder its progress and success in the market. Firstly, intense competition from established industry players and new entrants may erode the company's market share and squeeze profit margins. Furthermore, regulatory and compliance requirements within the healthcare industry pose a threat to the company's operations and product development timelines. Economic downturns and market uncertainties can also impact consumer spending, affecting the demand for Decision Diagnostics Corp's products and services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.